Design, Synthesis, Characterization, and In Vitro Evaluation of Isatin‐Pomalidomide Hybrids for Cytotoxicity against Multiple Myeloma Cell Lines
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, Synthesis, Characterization, and
In Vitro
Evaluation of Isatin‐Pomalidomide Hybrids for Cytotoxicity against Multiple Myeloma Cell Lines
Authors
Keywords
-
Journal
JOURNAL OF HETEROCYCLIC CHEMISTRY
Volume 55, Issue 12, Pages 2919-2928
Publisher
Wiley
Online
2018-10-19
DOI
10.1002/jhet.3365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, Synthesis andIn VitroAntiproliferative Activity of Novel Isatin-Quinazoline Hybrids
- (2015) Mohamed Fares et al. ARCHIV DER PHARMAZIE
- Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents
- (2015) Wagdy M. Eldehna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Abstract 4204: Isatin analog as bruton tyrosine kinase inhibitor: A promising novel agent for multiple myeloma treatment
- (2015) Krishne Gowda et al. CANCER RESEARCH
- β-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: Synthesis and antimalarial evaluation
- (2014) Nisha et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Azide-alkyne cycloaddition en route to 1 H -1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: Synthesis and antimalarial evaluation
- (2013) Raghu Raj et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, antitubercular and anticancer activity of new Baylis–Hillman adduct-derived N-cinnamyl-substituted isatin derivatives
- (2013) Sriramoju Bharath Kumar et al. MEDICINAL CHEMISTRY RESEARCH
- Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma
- (2013) Kai Liu et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- 1H-1,2,3-Triazole-Tethered Isatin–Ferrocene and Isatin–Ferrocenylchalcone Conjugates: Synthesis and in Vitro Antitubercular Evaluation
- (2013) Kewal Kumar et al. ORGANOMETALLICS
- Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
- (2013) A A Chanan-Khan et al. Blood Cancer Journal
- Prognostic significance of HOXB4 inde novoacute myeloid leukemia
- (2012) Shigeaki Umeda et al. Hematology
- Synthesis of New 4-Thiazolidinone-, Pyrazoline-, and Isatin-Based Conjugates with Promising Antitumor Activity
- (2012) Dmytro Havrylyuk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: A hybrid pharmacophore approach
- (2010) V. Raja Solomon et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives
- (2010) Lian-Shun Feng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents
- (2010) P. K. Ramshid et al. Medicinal Chemistry
- Design, synthesis, and QSAR study of novel 2-(2,3-dioxo-2,3-dihydro-1H-indol-1-yl)-N-phenylacetamide derivatives as cytotoxic agents
- (2010) Neha R. Modi et al. MEDICINAL CHEMISTRY RESEARCH
- Hybrid pharmacophore design and synthesis of isatin–benzothiazole analogs for their anti-breast cancer activity
- (2009) V. Raja Solomon et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis of 1H-Indole-2,3-Dione-3-Thiosemicarbazone Ribonucleosides as Antibacterial Agents
- (2009) Shaymaa E. Kassab et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Hybrid Molecules with a Dual Mode of Action: Dream or Reality?†
- (2007) Bernard Meunier ACCOUNTS OF CHEMICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation